Developing lipid nanoparticle-based siRNA therapeutics for hepatocellular carcinoma using an integrated approach.

Li L, Wang R, Wilcox D, Sarthy A, Lin X, Huang X, Tian L, Dande P, Hubbard RD, Hansen TM, Wada C, Zhao X, Kohlbrenner WM, Fesik SW, Shen Y
Mol Cancer Ther. 2013 12 (11): 2308-18

PMID: 23943805 · DOI:10.1158/1535-7163.MCT-12-0983-T

MeSH Terms (14)

Animals Carcinoma, Hepatocellular Cell Line, Tumor Drug Delivery Systems Female Genetic Therapy Hep G2 Cells Humans Liver Neoplasms Liver Neoplasms, Experimental Mice Mice, SCID Nanoparticles RNA, Small Interfering

Connections (1)

This publication is referenced by other Labnodes entities:

Links